San Diego we’ve arrived! The Acumen team is officially ready for @CTADconference on Alzheimer's Disease. We look forward to engaging with everyone during an exciting week focused on #Alzheimers!

This season reminds us of what truly matters. As we mark National Family Caregivers Month, we're grateful for the families, caregivers, advocates, and researchers who continue to move the #Alzheimers field toward a brighter future. #NationalFamilyCaregiversMonth #Gratitude

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredible team members and the amazing work they do! Click the link for full interview:  https://t.co/b2wzBG9nNb #AskAcumen #PeopleFirst #EmployeeSpotlight

Attending @CTADconference? We’ll have two poster presentations, one on our recruitment strategies for ALTITUDE-AD, and one on nonclinical Enhanced Brain Delivery – focusing on fusing transferrin receptor binders to sabirnetug. For more visit: https://t.co/Fb0V3le7p6 #CTAD25

We're pleased to announce that the first participant has been dosed in the open-label extension of our Phase 2 ALTITUDE-AD trial for #sabirnetug to support our continued development of this potentially differentiated therapeutic approach. Learn more: https://t.co/gnX8LqsPU3

👣Acumen team members have been showing up across the country for the @alzassociation "Walk to End Alzheimer's" events. Liean and Julie joined the Indianapolis walk in October; and this past weekend Mahsan walked in Oahu, HI. Kudos to all who participated! #Walk2ENDALZ

Today we announced our third quarter financial results and business highlights. 🔗Click link to read the release: https://t.co/jzv4cAQQym

Acumen is pleased to announce the addition of George Golumbeski, Ph.D., to our Board of Directors. Learn more about Dr. Golumbeski and the experience he brings to Acumen in the full announcement. 🔗 To read more, visit the link below https://t.co/AUuRLjEqAV

Yesterday Acumen team members hit the pavement in Boston, Charleston & Charlottesville for the @alzassociation 'Walk to End Alzheimer's'. Kudos to Laura, Jing, Amy, Dan, Kimber, and Rebecca, along with their families and friends for their commitment to the cause! #Walk2ENDALZ

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredible team members and the amazing work they do! Click the link for full interview:  https://t.co/b2wzBG9VCJ #AskAcumen #PeopleFirst #EmployeeSpotlight

We’re pleased to share this piece from @PharmaTechFocus on the rise of new U.S. biotech hubs and what they mean for the future of innovation. The article features insights from our CEO, Daniel O'Connell. Check out the article here:

Acumen's SVP of Clinical Development, Laura Rosen, MD, PhD, joined an expert panel at the Fluid & Imaging Biomarkers in Neuroscience Summit in Boston to discuss the promise of pTau217 in Alzheimer's Research. #AlzheimersResearch #Biomarkers #ClinicalDevelopment

#WorldMentalHealthDay reminds us that brain health is mental health. At Acumen, every moment matters—for patients, families, and each other—as we work to raise awareness, reduce stigma, and move science forward with compassion.

We’re proud to share that our team has published recruitment insights from the Phase 1 INTERCEPT-AD trial of sabirnetug (ACU193) in the journal Alzheimer’s & Dementia: Translational Research & Clinical Interventions. Read the full publication here: https://t.co/UiIm4Wwt0D

👣This past weekend Acumen team members hit the pavement for the @alzassociation's ''Walk to End Alzheimer's'' in the Twin Cities. Kudos to Robyn Moxon for her commitment to the cause! #EndAlz #TeamAcumen #WalkToEndAlzheimers #Walk2ENDALZ

Today is National Coffee Day! So many important moments happen over a coffee break: conversations, connections, ideas, reminders of what really matters. Here’s to holding on to those moments, and to making every one count. #EveryMomentMatters #NationalCoffeeDay

Yesterday, on World Alzheimer’s Day, Acumen team members along with their families & friends, joined hundreds of others in North Shore, IL and Bloomington, IN for the @alzassociation 'Walk to End Alzheimer’s'. #WalkToEndAlzheimers #Walk2ENDALZ #WorldAlzheimersDay

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredible team members and the amazing work they do! Click the link for full interview:  https://t.co/b2wzBG9VCJ #AskAcumen #PeopleFirst #EmployeeSpotlight

Acumen CEO Daniel O’Connell joined the 'Power to the Patients' Podcast to share how we’re reshaping the future of Alzheimer’s treatment – and why rebuilding patient trust is essential to that mission. You can listen to the full interview at: https://t.co/x8nUgycYZb #ALZ

We joined a fireside chat at the Cantor Global Healthcare Conference in NYC last week to discuss our momentum in Alzheimer’s research. Replay here: https://t.co/mZCbb0qx5Q #FiresideChat #Biotech #Alzheimers